Bionik Laboratories Corp. Stock
Stocks
BNKL
US09074A2087
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 23-06-27 | Bionik Laboratories Corp. Announces Executive Changes | CI |
| 23-06-21 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| Market Cap | 12 10.54 9.71 9.08 17.03 1.13K 17.34 116.52 45.13 558.17 45.06 44.08 1.94K | P/E 2022 |
-0.21x | P/E 2023 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98M 1.74M 1.61M 1.5M 2.82M 187M 2.87M 19.27M 7.47M 92.33M 7.45M 7.29M 321M | EV / Sales 2022 |
0.17x | EV / Sales 2023 | 2.65x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +9,900.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.64 | |
| 5 years | 0 | 2.9 | |
| 10 years | 0 | 222.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 46 | 2021-07-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Michal Prywata
BRD | Director/Board Member | 35 | 2019-03-17 |
| Director/Board Member | 70 | 2017-08-31 | |
Richard Russo
BRD | Director/Board Member | 46 | 2022-10-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-06-12 | Conversion | Chairman | 186,112 | 1.4416% | ||
| 23-06-12 | Conversion | Director | 3,102,878 | 24.0337% | ||
| 23-06-08 | Buy | Director | 180,555 | 1.3985% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | -.--% | -.--% | -99.98% | 1.26K | ||
| +0.93% | +9.93% | +23.77% | -2.29% | 188B | ||
| +1.97% | +1.01% | -23.81% | +25.18% | 142B | ||
| +1.30% | +9.55% | -3.11% | -17.94% | 137B | ||
| +1.37% | +0.90% | -57.23% | -16.39% | 65.7B | ||
| +1.04% | +5.04% | +16.93% | +0.80% | 51.66B | ||
| -0.55% | +0.03% | -26.90% | -32.25% | 43.7B | ||
| +0.76% | +7.93% | +14.32% | +15.33% | 38.27B | ||
| -0.56% | +4.87% | +5.86% | +44.64% | 37.01B | ||
| +1.48% | +8.15% | -12.39% | -15.70% | 29.54B | ||
| Average | +990.76% | +2.68% | -6.26% | -9.86% | 73.21B | |
| Weighted average by Cap. | +1.07% | +3.25% | -4.08% | +0.01% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.27M 1.12M 1.03M 964K 1.81M 120M 1.84M 12.37M 4.79M 59.25M 4.78M 4.68M 206M | 1.81M 1.59M 1.46M 1.37M 2.56M 170M 2.61M 17.53M 6.79M 83.97M 6.78M 6.63M 292M |
| Net income | -10.41M -9.14M -8.42M -7.88M -14.77M -982M -15.04M -101M -39.15M -484M -39.09M -38.23M -1.68B | -4.95M -4.34M -4M -3.74M -7.02M -467M -7.15M -48.03M -18.6M -230M -18.57M -18.17M -800M |
| Net Debt | -1.99M -1.75M -1.61M -1.51M -2.83M -188M -2.88M -19.34M -7.49M -92.63M -7.48M -7.31M -322M | 1.98M 1.74M 1.61M 1.5M 2.82M 187M 2.87M 19.27M 7.47M 92.33M 7.45M 7.29M 321M |
Employees
12
- Stock Market
- Stocks
- BNKL Stock
Select your edition
All financial news and data tailored to specific country editions
















